Lv7
3270 积分 2022-07-24 加入
Discovery of ZYDG2: a potent, selective, and safe GPR40 agonist for treatment of type 2 diabetes
24天前
已完结
An updated patent review of GPR40/ FFAR1 modulators (2020 – present)
29天前
已完结
Discovery of ZYDG2: a potent, selective and safe GPR40 agonist for treatment of type 2 diabetes
29天前
已完结
Discovery of potent free fatty acid receptor 1 full agonists with a novel scaffold bearing conjugated double bond linker
29天前
已完结
Synthetic GPR40/FFAR1 agonists: An exhaustive survey on the most recent chemical classes and their structure-activity relationships
29天前
已完结
Novel selective ligands for free fatty acid receptors GPR120 and GPR40
29天前
已完结
Vincamine as a GPR40 agonist shows potential in treating female Alzheimer’s disease
29天前
已完结
Transcription factor TFAP2A drives EMT progress by activating BDKRB1 transcription: The potential mechanism by which TFAP2A promotes idiopathic pulmonary fibrosis
1个月前
已完结
Ultrastructural localisation of protein interactions using conditionally stable nanobodies
2个月前
已关闭
Induced proximity pushes beyond protein degraders, as first RIPTAC moves into the clinic
2个月前
已完结
皖公网安备34019202002308
